Stockscreener 앱 받기
22.15
5.93%
1.24
시간 외 거래:
21.90
-0.25
-1.13%
전일 마감가:
$20.91
열려 있는:
$21.46
하루 거래량:
6.83M
Relative Volume:
2.44
시가총액:
$5.26B
수익:
$426.45M
순이익/손실:
$197.67M
주가수익비율:
27.01
EPS:
0.82
순현금흐름:
$110.10M
1주 성능:
+24.02%
1개월 성능:
+20.18%
6개월 성능:
+33.59%
1년 성능:
+270.40%
1일 변동 폭
$20.50
$22.25
1주일 범위
$17.30
$22.25
52주 변동 폭
$5.91
$23.64
Adma Biologics Inc Stock (ADMA) Company Profile
명칭
Adma Biologics Inc
전화
(201) 478-5552
주소
C/O ADMA BIOLOGICS, INC., RAMSEY
ADMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
22.15 | 5.26B | 426.45M | 197.67M | 110.10M | 0.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.49 | 128.67B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.91 | 60.99B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
605.38 | 36.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
230.93 | 29.89B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.84 | 25.73B | 3.81B | -644.79M | -669.77M | -6.24 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-19 | 재개 | Raymond James | Strong Buy |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2021-11-11 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-06-04 | 개시 | Jefferies | Buy |
| 2019-04-15 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-07 | 재개 | H.C. Wainwright | Buy |
| 2017-12-11 | 재확인 | Maxim Group | Buy |
| 2017-11-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | 업그레이드 | Maxim Group | Hold → Buy |
| 2016-08-01 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2016-07-25 | 재확인 | Maxim Group | Buy |
| 2015-05-13 | 재확인 | Maxim Group | Buy |
| 2014-12-08 | 개시 | Oppenheimer | Outperform |
| 2014-12-01 | 재확인 | Maxim Group | Buy |
모두보기
Adma Biologics Inc 주식(ADMA)의 최신 뉴스
Adma Biologics (ADMA) Just Overtook the 20-Day Moving Average - Zacks Investment Research
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo
Adma Biologics (ADMA) Moves 7.8% Higher: Will This Strength Last? - Yahoo Finance
Adma Biologics (ADMA) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
Why ADMA Biologics Inc. (ADMA) Skyrocketed On Monday? - Insider Monkey
Biotech Stocks Dominate Monday’s Top 10 Gainers - Insider Monkey
Axogen and ADMA Biologics expect low to zero impact from recent tariffs - MSN
ADMA Biologics says tariffs will not impact operations due to fully U.S.-based supply chain - ROI-NJ
Does Adma Biologics (ADMA) Have the Potential to Rally 51.75% as Wall Street Analysts Expect? - MSN
ADMA Biologics Says Tariffs Not Likely to Impact Supply Chain, Production Operations - MarketScreener
Adma BiologicsTariffs Expected To Have No Impact On Adma's Operations - MarketScreener
ADMA Biologics Statement on Tariffs - GlobeNewswire
ADMA's All-American Operations Shield Company From New Tariff Storm - Stock Titan
Wall Street Analysts Predict a 39.08% Upside in Adma Biologics (ADMA): Here's What You Should Know - MSN
Trading (ADMA) With Integrated Risk Controls - news.stocktradersdaily.com
Ensign Group Invests in Growth With New Facility Acquisitions - TradingView
ADMA STOCK DROP ALERT: ADMA Biologics, Inc. Stock Drops over 20%; BFA Law Initiates Securities Fraud Investigation and Urges Investors with Losses to Contact the Firm (Nasdaq:ADMA) - ACCESS Newswire
What's Driving the Market Sentiment Around ADMA Biologics? - Benzinga
Wall Street Analysts See Adma Biologics (ADMA) as a Buy: Should You Invest? - Yahoo Finance
Adma Biologics (ADMA) Stock Moves -0.15%: What You Should Know - Yahoo Finance
How IBD Stock Of The Day ADMA Biologics Shrugged Off Accounting Debacle For A Bullish Comeback - MSN
Adma Biologics (ADMA) Just Flashed Golden Cross Signal: Do You Buy? - Zacks Investment Research
Adma Biologics (ADMA) Surges 10.2%: Is This an Indication of Further Gains? - MSN
Adma Biologics CEO Adam Grossman sells $397,320 in stock By Investing.com - Investing.com Australia
Adma Biologics CEO Adam Grossman sells $397,320 in stock - Investing.com
Here is What to Know Beyond Why ADMA Biologics Inc (ADMA) is a Trending Stock - Yahoo Finance
ADMA Biologics: Premium Valuation Justified By Strong Fundamentals And Future Potential - Seeking Alpha
ADMA Stock Builds A Base As Profits Continue To Soar - MSN
Recent Price Trend in Adma Biologics (ADMA) is Your Friend, Here's Why - Yahoo Finance
Pulse of the Market: Wednesday’s 10 Top Performers - Insider Monkey
Decoding ADMA Biologics Inc (ADMA): A Strategic SWOT Insight - GuruFocus
Why ADMA Biologics Inc. (ADMA) Went Up On Wednesday? - Yahoo Finance
Why Adma Biologics (ADMA) Outpaced the Stock Market Today - MSN
Will ADMA Biologics Stock Continue Its Momentum in 2025? - Yahoo Finance
Should You Invest in Adma Biologics (ADMA) Based on Bullish Wall Street Views? - Yahoo Finance
Adma Biologics (ADMA) Recently Broke Out Above the 50-Day Moving Average - Yahoo Finance
Adma Biologics Inc (ADMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.98%
5.78%
자본화:
|
볼륨(24시간):